$6.1MSeries A, 25 November 2025
Funds building proprietary antibodies for identified diseases, which become company IP.
- Amount
- $6.1M
- Stage
- Series A
- Announced
- 25 November 2025
- Lead
- Ashish Kacholia
- Other investors
- pi Ventures, Anicut Capital, 3one4 Capital, AC Ventures
- Use of funds
- Funds building proprietary antibodies for identified diseases, which become company IP.
- Checked
- Amount and date checked against the press source
- Source
- immunitoAI bags $6.1 Mn from pi Ventures, others to develop antibody treatment inc42.com